189 related articles for article (PubMed ID: 15985467)
1. Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D.
Jansen S; Stefan C; Creemers JW; Waelkens E; Van Eynde A; Stalmans W; Bollen M
J Cell Sci; 2005 Jul; 118(Pt 14):3081-9. PubMed ID: 15985467
[TBL] [Abstract][Full Text] [Related]
2. Site-directed mutations in the tumor-associated cytokine, autotaxin, eliminate nucleotide phosphodiesterase, lysophospholipase D, and motogenic activities.
Koh E; Clair T; Woodhouse EC; Schiffmann E; Liotta L; Stracke M
Cancer Res; 2003 May; 63(9):2042-5. PubMed ID: 12727817
[TBL] [Abstract][Full Text] [Related]
3. The N-terminal hydrophobic sequence of autotaxin (ENPP2) functions as a signal peptide.
Koike S; Keino-Masu K; Ohto T; Masu M
Genes Cells; 2006 Feb; 11(2):133-42. PubMed ID: 16436050
[TBL] [Abstract][Full Text] [Related]
4. Substrate-specifying determinants of the nucleotide pyrophosphatases/phosphodiesterases NPP1 and NPP2.
Cimpean A; Stefan C; Gijsbers R; Stalmans W; Bollen M
Biochem J; 2004 Jul; 381(Pt 1):71-7. PubMed ID: 15096095
[TBL] [Abstract][Full Text] [Related]
5. Secretion and lysophospholipase D activity of autotaxin by adipocytes are controlled by N-glycosylation and signal peptidase.
Pradère JP; Tarnus E; Grès S; Valet P; Saulnier-Blache JS
Biochim Biophys Acta; 2007 Jan; 1771(1):93-102. PubMed ID: 17208043
[TBL] [Abstract][Full Text] [Related]
6. Lysophospholipids in the limelight: autotaxin takes center stage.
Moolenaar WH
J Cell Biol; 2002 Jul; 158(2):197-9. PubMed ID: 12135981
[TBL] [Abstract][Full Text] [Related]
7. Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells.
Jansen S; Andries M; Vekemans K; Vanbilloen H; Verbruggen A; Bollen M
Cancer Lett; 2009 Nov; 284(2):216-21. PubMed ID: 19482419
[TBL] [Abstract][Full Text] [Related]
8. The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site.
Gijsbers R; Aoki J; Arai H; Bollen M
FEBS Lett; 2003 Mar; 538(1-3):60-4. PubMed ID: 12633853
[TBL] [Abstract][Full Text] [Related]
9. An essential oligomannosidic glycan chain in the catalytic domain of autotaxin, a secreted lysophospholipase-D.
Jansen S; Callewaert N; Dewerte I; Andries M; Ceulemans H; Bollen M
J Biol Chem; 2007 Apr; 282(15):11084-91. PubMed ID: 17307740
[TBL] [Abstract][Full Text] [Related]
10. Functional invalidation of the autotaxin gene by a single amino acid mutation in mouse is lethal.
Ferry G; Giganti A; Cogé F; Bertaux F; Thiam K; Boutin JA
FEBS Lett; 2007 Jul; 581(18):3572-8. PubMed ID: 17628547
[TBL] [Abstract][Full Text] [Related]
11. Structure of NPP1, an ectonucleotide pyrophosphatase/phosphodiesterase involved in tissue calcification.
Jansen S; Perrakis A; Ulens C; Winkler C; Andries M; Joosten RP; Van Acker M; Luyten FP; Moolenaar WH; Bollen M
Structure; 2012 Nov; 20(11):1948-59. PubMed ID: 23041369
[TBL] [Abstract][Full Text] [Related]
12. Expression and transcriptional regulation of the PD-Ialpha/autotaxin gene in neuroblastoma.
Kawagoe H; Stracke ML; Nakamura H; Sano K
Cancer Res; 1997 Jun; 57(12):2516-21. PubMed ID: 9192834
[TBL] [Abstract][Full Text] [Related]
13. Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D.
van Meeteren LA; Brinkmann V; Saulnier-Blache JS; Lynch KR; Moolenaar WH
Cancer Lett; 2008 Aug; 266(2):203-8. PubMed ID: 18378389
[TBL] [Abstract][Full Text] [Related]
14. Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun.
Black EJ; Clair T; Delrow J; Neiman P; Gillespie DA
Oncogene; 2004 Mar; 23(13):2357-66. PubMed ID: 14691447
[TBL] [Abstract][Full Text] [Related]
15. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development.
van Meeteren LA; Ruurs P; Stortelers C; Bouwman P; van Rooijen MA; Pradère JP; Pettit TR; Wakelam MJ; Saulnier-Blache JS; Mummery CL; Moolenaar WH; Jonkers J
Mol Cell Biol; 2006 Jul; 26(13):5015-22. PubMed ID: 16782887
[TBL] [Abstract][Full Text] [Related]
16. The cellular localization of autotaxin impacts on its biological functions in human thyroid carcinoma cells.
Seifert A; Klonisch T; Wulfaenger J; Haag F; Dralle H; Langner J; Hoang-Vu C; Kehlen A
Oncol Rep; 2008 Jun; 19(6):1485-91. PubMed ID: 18497954
[TBL] [Abstract][Full Text] [Related]
17. Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression.
Boucher J; Quilliot D; Pradères JP; Simon MF; Grès S; Guigné C; Prévot D; Ferry G; Boutin JA; Carpéné C; Valet P; Saulnier-Blache JS
Diabetologia; 2005 Mar; 48(3):569-77. PubMed ID: 15700135
[TBL] [Abstract][Full Text] [Related]
18. Development of an activity-based probe for autotaxin.
Cavalli S; Houben AJ; Albers HM; van Tilburg EW; de Ru A; Aoki J; van Veelen P; Moolenaar WH; Ovaa H
Chembiochem; 2010 Nov; 11(16):2311-7. PubMed ID: 20941725
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.
van Meeteren LA; Ruurs P; Christodoulou E; Goding JW; Takakusa H; Kikuchi K; Perrakis A; Nagano T; Moolenaar WH
J Biol Chem; 2005 Jun; 280(22):21155-61. PubMed ID: 15769751
[TBL] [Abstract][Full Text] [Related]
20. Expression, regulation and function of autotaxin in thyroid carcinomas.
Kehlen A; Englert N; Seifert A; Klonisch T; Dralle H; Langner J; Hoang-Vu C
Int J Cancer; 2004 May; 109(6):833-8. PubMed ID: 15027116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]